Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abediterol dose-finding in persistent asthma
NCT01425801Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- Aug 2011
- Primary completion
- Feb 2012
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of abediterol in asthma, sponsored by AstraZeneca. Started Aug 2011; status: completed.
02
Drugs
abediterol
03
Conditions
asthma
Beyond the preview
Go deeper on NCT01425801.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01425801.